iConnectHub

Login/Register

WeChat

For more information, follow us on WeChat

Connect

For more information, contact us on WeChat

Email

You can contact us info@ringiertrade.com

Phone

Contact Us

86-21 6289-5533 x 269

Suggestions or Comments

86-20 2885 5256

Top

Solvay announces availability of Solviva? Biomaterials in China

Source:Solvay Specialty Polymers Release Date:2013-01-11 225
Plastics & Rubber
Expansion to meet growing asian demand for thermoplastic biomaterials in orthopedic and cardiovascular applications

The Solviva Biomaterials line of high-performance plastics for implantable applications – manufactured by Solvay Specialty Polymers – is now commercially available in China, the company has announced.  The biomaterials line, previously available in the U.S. and Europe, is targeted to meet growing demand in the Chinese market, complementing Solvay’s already extensive healthcare offering in China which includes medical polymers for non-implantable uses. Solvay will give a presentation on its Solvivaò Biomaterials offering during the annual meeting of China’s Surgical Implant Committee Jan. 11-14 in X’Ian City, China.

“With our broad product portfolio we are firmly positioned as a strategic supplier to the Chinese healthcare industry and this expansion in biomaterials signals our further commitment to national and multinational OEMs,” said Shawn Shorrock, global market manager for healthcare. “We are leveraging our position as a leading supplier of high-performance polymers to support applications from instrumentation to implants.” Solviva Biomaterials will primarily be targeted at orthopedic and cardiovascular applications.

The expansion into the high-growth Chinese market is a key element of Solvay’s global strategy to grow the Solviva Biomaterials line, according to Judy Melville, global business manager for Solviva Biomaterials. “This is an important first step that will unlock key business opportunities and firmly position us for future growth,” said Melville. She noted that the expansion into China is the first of a series of planned expansions into new global regions. Solvay will serve the Chinese market from its Shanghai facility where it operates research and development, sales, and commercial activities.

For implantable medical devices, the Solviva Biomaterials line includes Zeniva PEEK, which boasts a modulus very close to that of bone plus excellent biocompatibility, toughness, and fatigue resistance; Proniva self-reinforced polyphenylene (SRP), one of the world’s stiffest and strongest unreinforced thermoplastic that offers exceptional hardness and biocompatibility; Eviva polysulfone (PSU), which offers practical toughness in a strong, transparent polymer; and Veriva polyphenylsulfone (PPSU), which provides unsurpassed toughness combined with transparency and excellent biocompatibility.

Solviva Biomaterials can be sterilized via all conventional methods including gamma radiation, ethylene oxide, and steam. These products are available in resin for injection molding or extrusion, as well as stock shapes for machined components.

The entire line of thermoplastic Solviva Biomaterials is manufactured in compliance with the relevant aspects of ISO 13485 and under the relevant aspects of current Good Manufacturing Practices. Solvay’s biomaterial manufacturing processes are carefully validated and enhanced controls provide product traceability. In addition, all materials are tested in an accredited lab that isMen Shoes - Originals

You May Like